Please login to the form below

Not currently logged in
Email:
Password:

Zosano appoints Chris Krueger as chief business officer

He joins from Ardea Biosciences

Chris Kruger has joined Zosano Pharma as chief business officer.

He joins the US-based biopharma from Ardea Biosciences, where he served as senior VP and chief business officer.

During his time at Ardea, Krueger completed a $407m global partnership with Bayer HealthCare.

In his new role, he will be responsible for business development, legal, and investor relations activities of Zosano as it prepares to expand its efforts in developing drug's utilising its novel drug delivery system.

Additional previous roles Krueger has held include senior executive positions at Protemix, Xencor, X–Ceptor Therapeutics and Aurora Biosciences.

His experience includes a broad range of transactions, including licensing, strategic alliances, mergers and acquisitions and equity and debt financings.

"It's exciting for me to join the Zosano team as the company enters its next stage of corporate growth," said Krueger.

"With its novel transdermal drug delivery system, Zosano is poised to develop therapeutic products through its own efforts and through strategic collaborations."

12th April 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics